Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.
Hacke, W
Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I. [electronic resource] - Stroke Oct 1998 - 2073-5 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0039-2499
10.1161/01.str.29.10.2073 doi
Cerebrovascular Disorders--drug therapy
Humans
National Institutes of Health (U.S.)
Outcome Assessment, Health Care--statistics & numerical data
Plasminogen Activators--therapeutic use
Recombinant Proteins
Retrospective Studies
Tissue Plasminogen Activator--therapeutic use
United States
Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I. [electronic resource] - Stroke Oct 1998 - 2073-5 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
0039-2499
10.1161/01.str.29.10.2073 doi
Cerebrovascular Disorders--drug therapy
Humans
National Institutes of Health (U.S.)
Outcome Assessment, Health Care--statistics & numerical data
Plasminogen Activators--therapeutic use
Recombinant Proteins
Retrospective Studies
Tissue Plasminogen Activator--therapeutic use
United States